Drug Shortage Report for MIDAZOLAM INJECTION
Report ID | 82804 |
Drug Identification Number | 02423766 |
Brand name | MIDAZOLAM INJECTION |
Common or Proper name | MIDAZOLAM |
Company Name | PFIZER CANADA ULC |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | MIDAZOLAM |
Strength(s) | 5MG |
Dosage form(s) | SOLUTION |
Route of administration | INTRAMUSCULAR INTRAVENOUS |
Packaging size | 10 x 1mL AMP |
ATC code | N05CD |
ATC description | HYPNOTICS AND SEDATIVES |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2019-05-03 |
Estimated end date | |
Actual end date | 2019-06-05 |
Shortage status | Resolved |
Updated date | 2019-06-06 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v7 | 2019-06-06 | French | Compare |
v6 | 2019-06-06 | English | Compare |
v5 | 2019-05-08 | French | Compare |
v4 | 2019-05-08 | English | Compare |
v3 | 2019-05-04 | English | Compare |
v2 | 2019-04-30 | French | Compare |
v1 | 2019-04-30 | English | Compare |
Showing 1 to 7 of 7